Studying how fat tissue inflammation relates to liver fat in obesity
Studies inflammation in fat tissue and liver fat in adults with severe obesity.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Scottsdale, United StatesSee the site
- Trial code
- Registry title
- Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 20 Feb 2022
- Expected to end
- 30 Dec 2027
- Type of study
- Observational
- Treatments tested
- Bariatric surgery
- Record updated
- 28 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 30 to 70 with severe obesity who are going to have gastric bypass surgery.
- Age
- 30 to 70 years
- Sex
- All sexes can join. Women need a negative pregnancy test.
- Disease stage
- BMI greater than 40 kg/m2, with confirmed liver fibrosis of AUROC F=0 or F>2.
- Earlier treatment
- Must be undergoing gastric bypass surgery. Cannot be on glucocorticoid therapy, Plavix or Coumadin, or take antihistamines regularly.
- Biomarker or test result
- Normal TSH lab value.
Main reasons for not taking part
- Autoimmune diseases
- Hepatitis B or C positive
- Heavy alcohol use or active smoking history
- Active cancer history, asthma or COPD
- Blood donation within past 2 months
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Undergoing gastric bypass surgery
- Confirmed AUROC F=0 or F>2 liver fibrosis
- Age 30-70 years
- BMI greater than 40 kg/m2
- Negative pregnancy test (female only)
- Lab Values: Normal TSH
Who cannot take part
- Glucocorticoid Therapy
- Autoimmune diseases
- Hepatitis B or C positive
- Active cancer history
- History of asthma
- History of COPD
- Heavy alcohol use
- Active smoking history
- Taking Plavix or Coumadin
- Blood donation within past 2 months
- Taking antihistamine on regular basis
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 70 years old?
Where in United States
- Mayo Clinic in ArizonaScottsdale, United StatesContact: Stewart KeeganTaking people
About the trial
What the trial wants to find out
This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how this affects its appearance and function and ultimately insulin resistance.
The group in the trial
- Weight loss surgery
Gastric bypass surgery will be followed by weight loss as standard of care. Liver fibrosis by elastography will be determined before surgery.
Treatment: Bariatric surgery
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1
- Plain-language title
- Studying how fat tissue inflammation relates to liver fat in obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04232566, who can take part
- Record updated
- 28 January 2026